Apoptosis in prostate cancer: progressive and therapeutic implications (Review)

Area of Science:

• Oncology
• Molecular Biology

Background:

• Prostate cancer is a leading cause of cancer death in American men.
• Understanding molecular alterations is crucial for developing effective treatments.
• Impaired apoptosis is implicated in the progression of prostate cancer.

Purpose of the Study:

• To review recent advancements in understanding molecular events driving prostate cancer progression.
• To discuss the roles of key apoptosis regulators in prostate cancer.
• To explore the therapeutic implications of these molecules in human prostate carcinoma.

Main Methods:

• Literature review of recent scientific publications.
• Focus on key pro-apoptotic (p53, PTEN, caspases, Par-4) and anti-apoptotic (Bcl-2, NF-kappaB, Akt) molecules.
• Analysis of their roles in prostate cancer progression and therapeutic potential.

Main Results:

• Identified key molecular regulators involved in prostate cancer progression.
• Detailed the dual roles of apoptosis regulators in cancer development.
• Highlighted potential therapeutic targets based on molecular mechanisms.

Conclusions:

• Molecular alterations, particularly in apoptosis pathways, are critical for prostate cancer progression.
• Targeting specific pro- and anti-apoptotic molecules offers therapeutic potential.
• Further research into these pathways can lead to improved treatment strategies for prostate cancer.